Humacyte, Inc. (HUMA) Free cash flow 2020–2025
Humacyte, Inc. (HUMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$105.9MFY2025 · since FY2020: -$55.9M → -$105.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.9M | -6.3% |
| FY2024 | -$99.7M | -31.9% |
| FY2023 | -$75.6M | -4.7% |
| FY2022 | -$72.2M | +11.3% |
| FY2021 | -$81.4M | -45.7% |
| FY2020 | -$55.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HUMA financial trends
HUMA RevenueHUMA Net incomeHUMA Net marginHUMA Gross profitHUMA Gross marginHUMA Operating incomeHUMA Operating marginHUMA Operating cash flowHUMA Capital expendituresHUMA Return on equityHUMA Stock buybacksHUMA Dividends paidHUMA Total assetsHUMA Total liabilitiesHUMA Shareholders’ equityHUMA overview →